The Critical Path Institute (AZ, USA) have announced support from the European Medicines Agency (London, UK) for the measurement of glutamate dehydrogenase as a biomarker of hepatocellular live injury.
2D-LC–MS/MS to measure cleaved high-molecular-weight kininogen in human plasma as a biomarker for C1-INH-HAE
This research article describes a reagent-free LC–MS assay that has been developed for the quantitation of cHMWK, which was shown to be elevated in plasma of C1-INH-HAE patients due to C1-INH deficiency relative to that of healthy subjects.
A Swedish research team has identified a method of drug and disease detection through the analysis of various compounds in exhaled breath.
Researchers from Wayne State University School of Medicine (MI, USA) have indicated that RNA from sperm could be a promising determinant for a successful live birth and an indicator for the health of the child as they mature.
A novel optical biosensor has shown potential as a cheap and easy alternative to current diagnostic techniques.
Researchers have identified the DAG peptide as a potential biomarker for Alzheimer’s disease development.
Three single-nucleotide polymorphisms have been identified as viable candidates as biomarkers for the personalized monitoring and treatment of lung cancers.
At Reid 2017 we interviewed Jennifer Hincks, Principal Scientist at LGC, about her role in setting up a new flow cytometry service. Jennifer discusses her passion for flow cytometry, how it can be used to analyze biomarkers and how this field can be regulated and standardized.
At Reid 2017 we interviewed James Rudge, Global Microsampling Specialist at Neoteryx, about his role in developing volumetric absorptive microsampling. James talks about his interest in biomarkers, what technologies he uses to analyze biomarkers and how he thinks the ‘omics’ field will come online.
In this review, the authors discuss the use of biomarkers as diagnostic tools for human primary membranous nephropathy. Learn more in this article from Biomarkers in Medicine.